Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response (Q77317862)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 September 1998

Language	Label	Description	Also known as
English	Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response	scientific article published on 01 September 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

author name string

S A Rosenberg

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

J C Yang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

D E White

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

S M Steinberg

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

Annals of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

228

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

307-319

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9742914 AND SRC:MED&resulttype=core&format=json

4 December 2019

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma. A phase I study and a randomized prospective study comparing IL-2 alone versus IL-2 combined with PEG-IL

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term response data for 255 patients with metastatic renal cell carcinoma treated with high-dose recombinant interleukin-2 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/9742914

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77317862&oldid=1558236309"